human bioavailability is unknown Subcutaneous injection Human subcutaneous bioavailability and pharmacokinetics are unknown Factor Convenience Oral capsules No mixing or syringe math Subcutaneous injection Requires reconstitution, sterile supplies, and injection-site planning Factor Evidence limits Oral capsules No controlled human dose, benefit, or safety trial Subcutaneous injection No controlled human dose, benefit, or safety trial Factor Can the amounts be treated as equal
Not for Human or Veterinary Use.
5 days/week: Per week: 10 swabs 8 weeks: 80 swabs or 1 x 100-count box 12 weeks: 120 swabs or 2 x 100-count boxes 16 weeks: 160 swabs or 2 x 100-count boxes 3 times/week: Per week: 6 swabs 8 weeks: 48 swabs or 1 x 100-count box 12 weeks: 72 swabs or 1 x 100-count box 16 weeks: 96 swabs or 1 x 100-count box Planning note: Peptide and water totals are arithmetic minimums based on the listed schedule
BAC Water NZ | Bacteriostatic Water for Peptides NZ
You will answer a few questions about symptoms to help us prepare for your visit prior to scheduling your appointment
Tier discounts apply above the standard catalogue volume on each format, and labs running multi-replicate tendon repair models, parallel angiogenesis assays, or extended wound-closure protocols can lock in lead times and shipping windows through the quote process